Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Net Cash Flow (2023 - 2025)

Incannex Healthcare (IXHL) has disclosed Net Cash Flow for 3 consecutive years, with -$3.7 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow fell 136.56% to -$3.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $67.0 million through Dec 2025, up 669.07% year-over-year, with the annual reading at $8.9 million for FY2025, 155.2% up from the prior year.
  • Net Cash Flow hit -$3.7 million in Q4 2025 for Incannex Healthcare, down from $58.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $58.0 million in Q3 2025 to a low of -$6.0 million in Q3 2023.
  • Historically, Net Cash Flow has averaged $4.7 million across 3 years, with a median of -$2.2 million in 2023.
  • Biggest YoY gain for Net Cash Flow was 2674.25% in 2025; the steepest drop was 136.56% in 2025.
  • Year by year, Net Cash Flow stood at -$2.2 million in 2023, then rose by 27.38% to -$1.6 million in 2024, then tumbled by 136.56% to -$3.7 million in 2025.
  • Business Quant data shows Net Cash Flow for IXHL at -$3.7 million in Q4 2025, $58.0 million in Q3 2025, and $8.1 million in Q2 2025.